Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Carcinoma, Renal Cell × Zoledronic Acid × Clear all

Phase

Phase 2 3 Phase 4 1 Phase 3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 24 Prostatic Neoplasms 12 Neoplasm Metastasis 11 Multiple Myeloma 8 Osteoporosis 7 Pain 6 Fractures, Bone 4 Neoplasms, Plasma Cell 3 Lung Neoplasms 3 Humoral Hypercalcemia Of Malignancy 3 Carcinoma, Non-Small-Cell Lung 3 Bone Neoplasms 3 Spinal Cord Compression 2 Neoplasms 2 Lymphoma 2 Hematologic Neoplasms 2 Bone Diseases, Metabolic 2 Triple Negative Breast Neoplasms 1 Treatment of Bone Metastases 1 Small Cell Lung Carcinoma 1 Sarcoma, Ewing 1 Sarcoma 1 Paraproteinemias 1 Osteosarcoma 1 Neoplastic Processes 1 Lymphoma, Non-Hodgkin 1 Imaging Examination Shows at Least One Site With Bone Metastases From Soild Tumors 1 Hematologic Diseases 1 Giant Cell Tumor of Bone 1 Disease Progression 1

Interventions

Sunitinib 17 Nivolumab 12 pembrolizumab 10 Sorafenib 10 cabozantinib 9 Interferon-alpha 9 pazopanib 8 Everolimus 8 Bevacizumab 7 belzutifan 6 aldesleukin 6 Ipilimumab 6 lenvatinib 5 Magnetic Resonance Spectroscopy 5 Axitinib 5 atezolizumab 4 temsirolimus 3 Radiosurgery 3 Nephrectomy 3 Interferon alpha-2 3 tivozanib 2 durvalumab 2 avelumab 2 Specimen Handling 2 Saline Solution 2 Interleukin-2 2 G250 monoclonal antibody 2 Fluorouracil 2 Chemotherapy, Adjuvant 2 1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03408652 2021-10-22

MOSCAR

Centre Leon Berard

Phase 3 Terminated

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡